Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Enhanced Surveillance for New Vaccine Preventable Disease, Funding Opportunity

---
identifier: "/us/fr/E7-10246"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Enhanced Surveillance for New Vaccine Preventable Disease, Funding Opportunity"
title_number: 0
title_name: "Federal Register"
section_number: "E7-10246"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Enhanced Surveillance for New Vaccine Preventable Disease, Funding Opportunity"
positive_law: false
currency: "2007-05-29"
last_updated: "2007-05-29"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E7-10246"
document_type: "notice"
publication_date: "2007-05-29"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "72 FR 29501"
fr_volume: 72
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Enhanced Surveillance for New Vaccine Preventable Disease, Funding Opportunity

Announcement (FOA) IP07-001, Effectiveness of an Intervention to Promote Comprehensive Vaccination Programs in the Obstetrician-Gynecologist Setting, FOA IP07-008, and Impact of New Adolescent Vaccines on the Delivery of Recommended Clinical Preventive Services, FOA IP07-009

In accordance with section 10(a)(2) of the Federal Advisory

Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel.

*Time and Date:* 12 p.m.-4 p.m., June 15, 2007 (Closed).

*Place:* Teleconference.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of research grant applications in response to FOA IP07-001, “Enhanced Surveillance for New Vaccine Preventable Disease”, FOA IP07-008 “Effectiveness of an Intervention to Promote Comprehensive Vaccination Programs in the Obstetrician-Gynecologist Setting”, and FOA IP07-009 “Impact of New Adolescent Vaccines on the Delivery of Recommended Clinical Preventive Services”.

*Contact Person for More Information:* Trudy Messmer, PhD, Designated Federal Official, 1600 Clifton Road, Mailstop C-19, Atlanta, GA 30333, telephone (404) 639-2176.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: May 22, 2007.

Elaine L. Baker,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.